Search
for
Sort by
Research 30 of 1000+
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- From Primary MSC Culture of Adipose Tissue to Immortalized Cell Line Producing Cytokines for Potential Use in Regenerative Medicine Therapy or Immunotherapy
- Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata
- Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split‐face comparative study
- Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Sequential Immunotherapy with Tofacitinib and Low-Dose IL-2 Induces Sustained Remission in Alopecia Areata: A Proof-of-concept monocentric study
- 51721 Analysis for recurrence of alopecia areata after immunotherapy with diphenylcyclopropenone in 113 patients: A single-institution retrospective analysis
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Combination use of triamcinolone acetonide and immunotherapy as a new therapeutic option in alopecia totalis
- Combination use of triamcinolone acetonide and immunotherapy as a new therapeutic option in alopecia totalis
- Immunotherapy-Induced Scarring Alopecia: A Case Series
- Immunotherapy with imiquimod in cervical, vaginal, and vulvar intraepithelial lesions – a review of the literature
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
- Targeted immunotherapy for hair regrowth and regeneration
- Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus
- Immunotherapies
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Topical immunotherapy in alopecia areata
- Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
- Seventeen Cases of Alopecia Areata: Combination of SADBE Topical Immunotherapy with Other Therapies
- TOPICAL IMMUNOTHERAPY IN DERMATOLOGY
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies
- Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- Dapsone versus topical immunotherapy in alopecia areata